Press Releases

Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies

Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies.

Curebase Technology Key to metaMe Health’s FDA Clearance of Regulora

Clinical research for Regulora was successfully completed using Curebase’s decentralized clinical trial (DCT) technology and services.

NOORIK BIOPHARMACEUTICALS ANNOUNCES THE SIGNING OF A DEVELOPMENT CONTRACT WITH THE FEDERAL GOVERNMENT OF SWITZERLAND TO DEVELOP AMBRISENTAN AS A TREATMENT FOR SEVERE COVID-19

Noorik Biopharmaceuticals Ltd has signed a contract with the Federal Government of Switzerland to develop ambrisentan as a treatment for patients with severe COVID-19.

Novel Concepts Medical Groundbreaking Medicine Successfully Disrupted COVID-19 Spike Protein Attachment into Host Cells, Intended to Stop Omicron

Novel Concepts Medical (NCM) has announced the successful testing of its plant-based formulations for the treatment of SARS-CoV-2, the virus responsible for the COVID-19 pandemic.

SureClinical Launches Eclinical Ecosystem™ ECO Bundle to Support Clinical Trial Automation and Collaboration

SureClinical Inc, a leading provider of cloud-native eClinical applications, announces the launch of its new Eclinical Ecosystem ECO Applications and Platform Bundle. Designed for the unique needs of Clinical Research Organizations, the ECO Bundle connects people, programs, projects and processes for a singular view of clinical data.

Curebase Joins WCG Avoca Quality Consortium

Curebase Joins WCG Avoca Quality Consortium

Ribo-Seq Service Now Available on CD Genomics’s RNA Solutions Platforms

RNA Solutions is the platform that offers services on the revolutionizing study of RNA, targeting both coding and non-coding RNAs of different physiological functions. The scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. To further enrich its service types, the company recently announced to add Ribo-Seq to its offerings.

Epigenetics Data Analysis Service Now Available by CD Genomics’s Bioinformatics-Analysis Platform

Bioinformatics-analysis Platform is a leading open solution for data-driven innovation, which aims to discover the hidden potential in biological data and unearth new insights or predict new prospects related to life science research. CD Genomics has recently announced Epigenetics Data Analysis to move your disease research forward.

DDA Platform Offers Wide Range of Genetoxicity Testing Services to Accelerate Different Phases of Drug Discovery

Acroscell Offers Cardiac Ion Channel Screen Panels to Detect and Analyze Effects of Candidate Drugs

Creative Bioarray Develops State-of-art Cell Based Assay to Support Biomedical Research and Drug-discovery Process

Microbialtec Platform Develops Chemotaxonomy-based Drug Discovery to Accelerate The Development of Drug Discovery

IntegrateRNA Develops One-stop Solutions for Oligonucleotide Conjugation Services to Facilitate Diagnostic and Targeted Drug Delivery

Microbiosci Offers Reliable Strain Selection and Fermentation Services to Suit The Needs of Microbial Research

Certified Reference Materials for Chromatography Are Now Available at Alfa Chemistry

BOC Sciences Promotes Drug Development by Pharmaceutical Impurity Identification

CD Genomics Fully Supports Your Microbiome Research with Comprehensive Sequencing Solutions

CD Formulation Optimizes Elemental Impurities Analysis Service

Biotium Introduces Unique Super-Sensitive RNA Prestain Loading Dye

Biotium has announced the release of EMBER500™ RNA Prestain Loading Dye.

Emmes Acquires Institut Dr. Schauerte